Finland· FI-REL-REL2257
Solomet Depot C. Bupivacain. Hydrochlorid.
A methylprednisolon, kombinationen product containing methylprednisolone acetate + bupivacaine hydrochloride monohydrate, registered in Finland by Orion Corporation. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Methylprednisolon, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC H02BX01 (methylprednisolon, kombinationen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Methylprednisolon, kombinationen · ATC H02BX01
6 / 19 countries
- Canada
- Finlandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Methylprednisolone acetate + Bupivacaine hydrochloride monohydrate
- Manufacturer
- Orion Corporation
- Country
- Finland (FI)
- ATC code
- H02BX01
- ATC class
- Methylprednisolon, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under H02BX01
Methylprednisolon, kombinationen, as other registers publish it.
- NetherlandsDepo Medrol + Lidocaïne, suspensie voor injectiePfizer B.V.
- SwitzerlandDepo Medrol Lidocain
- SwitzerlandDepo Medrol Lidocain
- SwitzerlandDepo Medrol Lidocain
- FinlandDepo-Medrol Cum LidocainPfizer Oy
- SwitzerlandDepo-Medrol Lidocaine 40 mg/mL, InjektionssuspensionPfizer AG
- SwitzerlandDepo-Medrol Lidocaine 80 mg/2 mL, InjektionssuspensionPfizer AG
- CanadaDEPO-MEDROL WITH LIDOCAINEPFIZER CANADA ULC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2cc0e0b8-e044-4fad-8f66-f627c35f7e19 GET /v1/drugs/2cc0e0b8-e044-4fad-8f66-f627c35f7e19?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.5",
"form": "injektioneste, suspensio",
"route": "Limapussin sisään",
"ddd_unit": "ED",
"strength": "40 mg/ml + 5 mg/ml",
"atc_label": "metyyliprednisoloni, yhdistelmävalmisteet",
"ma_number": "9662",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL2257",
"authorised_at": "1988-05-11"
}See everything about methylprednisolon, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.